Vivani Medical (VANI) logo

Vivani Medical (VANI) stock

Drug implants , market cap $98.3M

$1.14
+4.59%

Quality Score
0
Below Average
In its industry
#66of 86
Checks firing
4of 14
Transition
From 52-week high
-31.4%
under its best in a year
See VANI's 14 chart checksSee VANI's 14 chart checksSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why VANI lags the market

Down 16% in a year while the S&P 500 rose 7%.

  • Its $14.6M in cash covers about 2 quarters at the past year's pace, and its net loss widened.
  • Arithmetic on filed figures, not a forecast.

Sources: Price history, Nov 20, 2026; Latest balance sheet, Nov 12, 2026; Company release, Nov 12, 2026

1 more reason, free with an account →See every reason on VANI →3 more reasons why VANI lags the market, from its filings, with how the business stands, the company's words, and the timeline, for Pro members.

Key facts on VANI

Key facts on VANI
Holding it back50.9% more shares than a year ago from Massive's market data
Latest filing8-K, Nov 16 Sold shares in an unregistered sale

VANI catalysts

Coming up

After its last 4 reports it closed -2.6% on average, higher 2 of 4 times.

Why VANI scores 0

Below Averagefor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means

  • +4Chart checks 4 of 14 firing right now, one point each
  • −3Long-term trend below a falling 200-⁠day average, down over one year, down over two years
  • Size subtracts
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Dilution subtractsNew shares over the year: -1 at 10% more, -2 at 25% more.
  • Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
  • Cash flow subtracts-1 when free cash flow over the last four quarters is negative.
  • News adds
  • Insider trades adds

No effect today: Run-up, Growth, and Persistence.

What every line is worth, and the reason behind it, on VANI and every other stock.Get in free →See the top 3 →Start Pro

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:50 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when VANI's Quality Score turns up

A free account. No card.Pro: $1 first month.Pro, 7 days free with a card.

How VANI ranks in Medical Devices

VANI is #66 of 86 by Quality Score.

How VANI ranks in Medical Devices
RankStockQuality Score
66Vivani Medical (VANI) logoVANIVivani Medical0

More in Medical Devices

When does VANI report earnings, and what happens after?

Expected to report Thu Mar 25, after the close (in 124 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What VANI reported on Nov 12, 2026

The quarter

The figures are not read from the release yet.

“The increase of $0.5 million, or 11%, was primarily attributable to an increase in the clinical trial related expense from our Biopharm Division.”

The filing on EDGAR

Where the sales came from

VANI's results filing gives no sales by line in a table we read.

The outlook

No outlook figures read from this release.

In the company's words

  • “The increase of $0.3 million, or 14%, was primarily attributable to an increase in personnel and related expenses from our Neurostimulation Division and our Biopharm Division.”

From its results filing (SEC filing · Nov 12)

1 more sentence, for Pro members.

The numbers

Market value
$98.3M
today
Sales
$0
last fiscal year
Loss
$26.6M
last fiscal year
Free cash flow
-$25.5M
last fiscal year

1 more figure, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on VANI: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

+3.5%+4.5%-13.0%
May 13Aug 13Nov 12
ReportedGapReaction5
days
Nov 12, 2026Before open-0.9%-13.0%-7.1%
Aug 13, 2026After close0.0%+4.5%+5.2%
May 13, 2026After close-3.5%+3.5%+2.6%

VANI closed higher after 2 of its last 4 reports.

All 4 reports, and VANI's Quality Score going into each

VANI sales and profit by year

Sales and profit by year

Sales grew in one of the last four years, to $0 in 2025. It lost money in each of the six years.

VANI has 4 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on VANI, and all 14 on every stock.Get in free →See the top 3 →Start Pro

VANI RSI on Nov 20: 54.2, below its 50-day and 200-day averages

Not scored

RSI 54.2, MACD above signal, below both averages. Not scored.

The deep dive on VANI

  • What it does and how it makes money1 findingFor Pro members1 finding on what VANI does and how it makes money, for Pro members
  • What changed in its filings3 findings"On June 12, 2025, the Court granted the Company’s motion in part and denied it in part, dismissing all claims except the first cause of action for breach of contract (the 'Claim'), and the Court dismissed the complaint as against the Third Party." (10-K for fiscal 2025)SEC filing · Mar 26, 2026
  • Who holds and trades it3 findingsInsiders bought $229K of shares on the open market in 90 days, with no sales; the largest, 10% owner Gregg Williams, bought $93K on Nov 19, 2026.Form 4, filed Nov 20, 2026

5 more findings on VANI, each with its source, for Pro members.

VANI share count over time

Shares: 37.2% more than a year ago (to Dec 31).

Shares of VANI outstanding, as filed
Shares
outstanding
As
of
90.2MNov 12, 2026
90.2MAug 13, 2026
86.2MMay 12, 2026
84.6MMar 25, 2026
Offerings, shelves, and splits of VANI, from its filings
From its
filings
Filed
Unregistered sale of VANI sharesNov 16, 2026
Raised $2.5M in a sale of shares, about 3% of its market valueJan 27, 2026
Raised $9.7M in a sale of shares, about 10% of its market valueOct 28, 2025

VANI insider trades

2 insiders bought $229K across 7 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyGregg Williams$93K10% ownerat $1.10 on Nov 19, filed yesterday

All 7 insider filings on VANI from the last six months, for Pro members.

All VANI insider trades

VANI's officers and directors

Officers and directors with a Form 4 in the last 12 months.

See insider trades by person

Which ETFs hold VANI?

In ETFs: VANI is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Vivani Medical

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

36 employeesAlameda, CAvivani.com

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on VANI and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn VANI's score around: 8 things
  • 7 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayyesterdayGregg Williams bought VANI$93K at $1.09, filed Nov 20

Alerts are optional.

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 21, 2026: VANI's Quality Score is 0 (Below Average), #66 of 86 in Medical Devices. Insiders bought $229K in the last 6 months (Form 4).

What does VANI's Quality Score say?

VANI scores 0 today, which Breakaway calls Below Average. It is #66 of 86 in Medical Devices by Quality Score, with 4 of 14 chart checks firing. Down 16% in a year while the S&P 500 rose 7%. Shares: 37.2% more than a year ago (to Dec 31). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is VANI's Quality Score?

VANI scores 0 today, which Breakaway calls Below Average (0 to 5). That is #66 of 86 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind VANI's 0.

Are insiders buying VANI?

2 insiders bought $229K across 7 filings in the last 6 months. No open-⁠market sales on record. The newest is Gregg Williams, 10% owner, who bought $93K on Nov 19. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,170 stocks rankedSee all 3,170 stocks rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.